Robert J. Gould

2019 - Fulcrum Therapeutics

In 2019, Robert J. Gould earned a total compensation of $3.9M as President and Chief Executive Officer at Fulcrum Therapeutics, a 356% increase compared to previous year.

Compensation breakdown

Bonus$300,000
Option Awards$3,111,158
Salary$478,195
Total$3,889,353

Gould received $3.1M in option awards, accounting for 80% of the total pay in 2019.

Gould also received $300K in bonus and $478.2K in salary.

Rankings

In 2019, Robert J. Gould's compensation ranked 3,081st out of 13,971 executives tracked by ExecPay. In other words, Gould earned more than 77.9% of executives.

ClassificationRankingPercentile
All
3,081
out of 13,971
78th
Division
Manufacturing
1,113
out of 5,701
81st
Major group
Chemicals And Allied Products
377
out of 2,200
83rd
Industry group
Drugs
310
out of 1,886
84th
Industry
Pharmaceutical Preparations
228
out of 1,398
84th
Source: SEC filing on April 29, 2020.

Gould's colleagues

We found two more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2019.

2019

Owen Wallace

Fulcrum Therapeutics

Chief Scientific Officer

2019

Bryan Stuart

Fulcrum Therapeutics

Chief Operating Officer

News

In-depth

You may also like